Literature DB >> 35829932

Social networks as education strategies for indigenous patients with rheumatoid arthritis during COVID-19 pandemic. Are they useful?

Rosana Quintana1, Sofia Fernandez2, Lourdes Guggia2, Martina Fay2, Cecilia Camacho2, Graciela Gomez2, Jazmin Petrelli2, Andrés Honeri2, Viviana Arenas Solórzano2, Ana Bensi2, Maria Elena Calvo3, Ingris Pelaez-Ballestas4, Marcela Valdata2, Bernardo A Pons-Estel2.   

Abstract

INTRODUCTION: The use of online education strategies has been introduced as a tool to support health care in patients with rheumatic disease. However, it is important to consider the patient's sociocultural environment.
OBJECTIVE: To design and assessment of bilingual audiovisual material acceptability, by means of two social networks, for patients with rheumatoid arthritis (RA) in the qom community in Argentina.
METHODS: A qualitative study was performed in two stages: (1) audiovisual material design, development, and validation implementing a collaborative action research method. (2) Publishing of the material on two social networks at two different times. The selected topic was the coronavirus disease 2019 impact on patients with RA. A qualitative and quantitative data analysis was performed.
RESULTS: Forty subjects participated into the initial validation stage with a 70% acceptance rate. First, 28 subjects (70%) participated on Facebook and 25 (62.5%) joined the WhatsApp group. Then, the same number of subjects participated on Facebook, while only 45% of subjects participated on WhatsApp. Most of them participated using short phrases such as "I like it." The 60% of the participants played the videos. However, less than 10% shared them. Videos in Spanish were the once most shared. Participation dramatically fell during the second time, and 40% of the WhatsApp subjects never participated.
CONCLUSION: The strategies developed for this indigenous community were of no utility, probably because of socio-cultural, economic, and digital barriers. They should be designed and implemented identifying the target group and its environment. Key Points • Online education strategies should be designed with cultural sensitivity. • Technological barriers make digital inequality visible in vulnerable groups. • Educational interventions should have a collaborative design and they should be created together with the communities. • The COVID-19 pandemic has deepened inequalities in the health care and follow-up of patients with rheumatic diseases, especially between most socially and economically disadvantaged groups.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Audiovisual educational material; Digital inequality; Multidisciplinary approach; Patient health education; Qom population

Mesh:

Year:  2022        PMID: 35829932     DOI: 10.1007/s10067-022-06273-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  3 in total

Review 1.  Seeking consent for research with indigenous communities: a systematic review.

Authors:  Emily F M Fitzpatrick; Alexandra L C Martiniuk; Heather D'Antoine; June Oscar; Maureen Carter; Elizabeth J Elliott
Journal:  BMC Med Ethics       Date:  2016-10-22       Impact factor: 2.652

2.  Fears and beliefs of people living with rheumatoid arthritis: a systematic literature review.

Authors:  Penélope Esther Palominos; Andrese Aline Gasparin; Nicole Pamplona Bueno de Andrade; Ricardo Machado Xavier; Rafael Mendonça da Silva Chakr; Fernanda Igansi; Laure Gossec
Journal:  Adv Rheumatol       Date:  2018-05-24

3.  Clinical and bioethical implications of health care interruption during the COVID-19 pandemic: A cross-sectional study in outpatients with rheumatic diseases.

Authors:  Guillermo A Guaracha-Basáñez; Irazú Contreras-Yáñez; Gabriela Hernández-Molina; Anayanci González-Marín; Lexli D Pacheco-Santiago; Salvador S Valverde-Hernández; Ingris Peláez-Ballestas; Virginia Pascual-Ramos
Journal:  PLoS One       Date:  2021-07-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.